Abstract: An apparatus for checking the tightness of a closure of a container, in particular a pharmaceutical or cosmetic container, the closure comprising a closure cap for closing the container and an elastic sealing member arranged between the closure cap and a mouth edge of the container, comprising: a turntable movable relatively against the closure of the container for exerting a compressive force on the elastic sealing member to effect compression of the elastic sealing member, wherein the turntable is connected to an axially displaceable drive shaft of a drive unit, and wherein the turntable is configured to be set in rotation with the container coupled thereto; a crimping device for crimping the closure cap; a control unit for controlling the drive unit; and a position encoder for providing a value representing a stroke position of the turntable.

Abstract: The present invention relates to a method for purification of a polymer material from plastic waste, wherein said polymer material comprises at least one target polymer, at least one non-target polymer and at least one impurity, wherein the method comprises the steps of providing said plastic waste in solid form; dissolving said polymer material; optionally, a first liquid-solid separation step; optionally, adding at least one additive; precipitating the at least one impurity and the at least one non-target polymer from the solution; optionally, adding at least one additive; separating the precipitate; optionally, adding at least one additive and separating the at least one additive and adsorbed remaining impurities; removing the residual solvent and, optionally degassing the purified target polymer material. The present invention further relates to a recyclate obtainable by said method.

Abstract: An apparatus for checking the tightness of a closure of a container, in particular a pharmaceutical or cosmetic container, the closure comprising a closure cap for closing the container and an elastic sealing member arranged between the closure cap and a mouth edge of the container, comprising: a turntable movable relatively against the closure of the container for exerting a compressive force on the elastic sealing member to effect compression of the elastic sealing member, wherein the turntable is connected to an axially displaceable drive shaft of a drive unit, and wherein the turntable is configured to be set in rotation with the container coupled thereto; a crimping device for crimping the closure cap; a control unit for controlling the drive unit; and a position encoder for providing a value representing a stroke position of the turntable.

Abstract: A heavy-duty lift truck designed as a mast-based apparatus comprising a mast, a load accepting means is mounted on the mast in such a way that it can be raised and lowered, and the heavy-duty lift truck is designed at least for a load capacity of 8 tons, with the heavy-duty lift truck comprising a powertrain with a travel drive that comprises an electric drive unit whereby the heavy-duty lift truck has greater energy efficiency.

Abstract: A heavy-duty lift truck designed as a mast-based apparatus comprising a mast, a load accepting means is mounted on the mast in such a way that it can be raised and lowered, and the heavy-duty lift truck is designed at least for a load capacity of 8 tons, with the heavy-duty lift truck comprising a powertrain with a travel drive that comprises an electric drive unit whereby the heavy-duty lift truck has greater energy efficiency.

Abstract: The invention relates to compounds capable of inhibiting the visual cycle and/or dark adaptation and their use for treatment and prevention of non-degenerative retinal diseases with specific emphasis on the prevention and treatment of diabetic retinopathy, retinopathy of prematurity, branch retinal vein occlusion, central retinal vein occlusion, open-angle glaucoma, veovascular glaucoma, and other diseases of the retinal and/or optic nerve where an imbalance between metabolic demand and blood supply contribute to the development of tissue damage. The invention furthermore relates to pharmaceutical compositions comprising such compounds.

Abstract: A system and method for presenting advertising is implemented by an advertisement server having a database of products organized in a hierarchy of themes, an interface module web server configured to analyze content of a web page to identify one or more themes of the web page, and a user terminal configured to access the web page and configured for presenting advertisements from the database that have themes matching the web page themes.

Abstract: A system and method for displaying information on mobile devices via a user interface (UI) includes an overlay structure on top of an application or web page which shows content related to a product or service. The overlay structure on top of an application or web page showing content related to the promoted product enables user action such as purchasing the product or service without taking the user away from the original view used for accessing the information.

Abstract: A method for determining item specific user interest includes rendering a tag on top of a content item of a website, activating an e-commerce application from the tag related to the content item, and rendering a second item related to the content item on the e-commerce application. The method also includes monitoring one or more actions performed by the user related to the item on the e-commerce application. The method further includes assigning scores to the one or more actions performed by the user related to the item. In addition, the method includes determining a level of interest value of the user for the item based on scores assigned to the one or more actions.

Abstract: The aspects of the disclosed embodiment provide a method and system for user-controlled rendering of mobile advertisements and for context based targeting of content to users. The method includes collecting information associated with location of a user and content displayed on a user device. One or more relevant advertisements are identified based on the information which is collected from the user device. An option to view the one or more relevant advertisements is displayed on the user device. The relevant advertisement(s) are displayed on the user device when the user selects the option to view the advertisement. The method further includes identifying an element of a web page for targeting one or more content on the element. Additionally the method further includes identifying one or more characteristics of the element, wherein the one or more characteristics are identified for determining a context of the element.

Abstract: The invention related to a method and a system for non- or minimally disruptive photomanipulation of the lens and/or its constituents collectively or selectively of an animal or human eye, comprising focusing a treatment laser beam into a selected part of the lens and/or its constituents collectively or selectively where treatment is intended to occur, pulsing of said treatment laser beam, scanning the beam over at least a part of the lens, measuring one or more types of radiation from the said selected part and utilizing this measurement to decide to stop the said treatment laser beam or to adjust at least one of the parameters: focus, intensity, wavelength, pulse length, repetition frequency, pulse train length, scan velocity, size of scanned volume, scan repetitions, and scan pattern of said treatment laser beam.

Abstract: Embodiments of the invention are concerned with showing information such as advertisements in website pictures. Advertisements are shown in web site as some of the embedded pictures in the web site are hovered. According to embodiments advertisements can be related to content of such hovered pictures such as products shown in the pictures.

Abstract: The invention related to a method and a system for non- or minimally disruptive photomanipulation of the lens and/or its constituents collectively or selectively of an animal or human eye, comprising focusing a treatment laser beam into a selected part of the lens and/or its constituents collectively or selectively where treatment is intended to occur, pulsing of said treatment laser beam, scanning the beam over at least a part of the lens, measuring one or more types of radiation from the said selected part and utilizing this measurement to decide to stop the said treatment laser beam or to adjust at least one of the parameters: focus, intensity, wavelength, pulse length, repetition frequency, pulse train length, scan velocity, size of scanned volume, scan repetitions, and scan pattern of said treatment laser beam.

Abstract: A power conversion system comprising at least one Pulse Modulated Amplifier (1), including a pulse modulator for generating a pulse modulated signal based on a reference input (vi), a switching power stage arranged to amplify the pulse modulated signal, and a control system arranged to compensate for power supply voltage variations, and a voltage supply (2) providing drive voltage (Vs) to each amplifier, wherein said voltage supply (2) is provided with said input reference (vi), and arranged to provide a first drive voltage component (Vs) tracking an amplified absolute value of the input reference (vi). Pulse area modulation according to the invention will result in improved efficiency and at the same time ensure lower levels of EMI, as the mean amplitude of the PAM signal is lowered.

Abstract: A pulse modulation power converter comprising a forward path including a forward block (15), a switching stage (11) for amplifying an output from the forward block, and an output filter (12) for low pass filtering an output signal from the switching stage, a global feedback path (13), connected to the low pass filtered output signal, comprising a global feedback block (18, 19) for generating a feedback signal, and means (14) for subtracting said feedback signal from an input signal, and feeding the result to said forward path. The global feedback block and/or forward block includes means for compensating at least a portion of a phase lag of said output filter, and means for obtaining a 180 degrees phase lag at a switching frequency, thereby achieving conditions for a controlled oscillation at said switching frequency. The control system combines the advantages of the self-oscillation technology with a high gain, wide-band control loop for suppressing non-linearities.

Abstract: The invention relates to the use of a matrix metalloproteinase inhibitor and a cyclosporin in combination therapy for treating mammals suffering from arthritic diseases such as rheumatoid arthritis.

Abstract: Stem cell inhibitors such as murine and human macrophage inflammatory protein-1alpha (muMIP-1alpha and huMIP-1alpha/LD78) and their analogues and variants enhance the release and mobilization of haematopoietic cells. This property makes them useful in enhancing responses against infection and in cell harvesting.

Abstract: Compounds of formula (I), wherein: A represents: a) a --VR.sup.6 group wherein v is --C(.dbd.O), --C(.dbd.O)O--, --CH.sub.2 O--, --CH.sub.2 OC(.dbd.O)--, --C(.dbd.S)--, --CH.sub.2 OC(.dbd.O)NH--, --C(.dbd.S)O--, --CH.sub.2 S--, --C(.dbd.O)NHSO.sub.2 --, --SO.sub.2 NHC(.dbd.O)-- or --CH.sub.2 OSiPh.sub.2 --; b) a --CH.sub.2 NR.sup.9 R.sup.10 group or a --CONR.sup.9 R.sup.10 group wherein each of R.sup.9 and R.sup.10 is independently hydrogen, -alkyl-, -alkenyl-, -alkynyl, -cycloalkyl, -cycloalkenyl, pyridyl (any of which may optionally be substituted) or a group --D as defined above or R.sup.9 and R.sup.10 together with the nitrogen atom to which they are attached form a nitrogen-containing heterocyclic ring; c) a group Y where Y is a 5- or 6-membered optionally substituted heterocyclic ring containing one or more heteroatoms selected from nitrogen, oxygen and sulphur; or d) a group --CH.sub.2 Y or --C(.dbd.

Abstract: The invention disclosed relates to thrombolytic combination therapy by the administration of an agent capable of activating native plasminogen, and a non-native plasminogen analogue which is cleavable by native thrombin to generate plasmin activity.